肌萎缩
医学
重症监护医学
阻力训练
干预(咨询)
物理疗法
内科学
精神科
作者
Yves Rolland,Graziano Onder,John E. Morley,Sophie Gillette-Guyonet,Gabor Abellán van Kan,Bruno Vellas
标识
DOI:10.1016/j.cger.2011.03.008
摘要
Sarcopenia is a complex multifactorial condition that can by treated with multimodal approaches. No pharmacologic agent to prevent or treat sarcopenia has been as efficacious as exercise (mainly resistance training) in combination with nutritional intervention (adequate protein and energy intake). However, performing resistance training sessions and following nutritional advice can be challenging, especially for frail, sarcopenic, elderly patients, and results remain only partial. Therefore, new pharmacologic agents may substantially reduce the functional decline in older people. This article reviews the new pharmacologic agents currently being assessed for treating sarcopenia.
科研通智能强力驱动
Strongly Powered by AbleSci AI